Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

Exploring the potential of neuroproteomics in Alzheimer's disease

  • Md Sahab Uddin*
  • , Md Tanvir Kabir
  • , Md Jakaria
  • , Eduardo Sobarzo-Sánchez
  • , George E. Barreto
  • , Asma Perveen
  • , Abdul Hafeez
  • , May N. Bin-Jumah
  • , Mohamed M. Abdel-Daim
  • , Ghulam M. Ashraf*
  • *Autor correspondiente de este trabajo
  • Southeast University, Dhaka
  • Neuroscience Research Network
  • BRAC University
  • The University of Melbourne
  • Instituto de Investigación e Innovación en Salud
  • Department of Organic Chemistry
  • Universidad Santiago de Compostela
  • University of Limerick
  • Universidad Autonoma de Chile
  • Glocal University
  • Princess Nourah Bint Abdulrahman University
  • King Saud University
  • Faculty of Veterinary Medicine
  • King Fahd Medical Research Center
  • Faculty of Applied Medical Sciences, King Abdulaziz University

Producción científica: Contribución a una revista › Artículo › revisión exhaustiva

18 Citas (Scopus)

Resumen

Alzheimer's disease (AD) is progressive brain amyloidosis that damages brain regions associated with memory, thinking, behavioral and social skills. Neuropathologically, AD is characterized by intraneuronal hyperphosphorylated tau inclusions as neurofibrillary tangles (NFTs), and buildup of ex-tracellular amyloid-beta (Aβ) peptide as senile plaques. Several biomarker tests capturing these patholo-gies have been developed. However, for the full clinical expression of the neurodegenerative events of AD, there exist other central molecular pathways. In terms of understanding the unidentified underlying processes for the progression and development of AD, a complete comprehension of the structure and composition of atypical aggregation of proteins is essential. Presently, to aid the prognosis, diagnosis, detection, and development of drug targets in AD, neuroproteomics is elected as one of the leading essential tools for the efficient exploratory discovery of prospective biomarker candidates estimated to play a crucial role. Therefore, the aim of this review is to present the role of neuroproteomics to analyze the complexity of AD.

Idioma originalInglés
Páginas (desde-hasta)2263-2278
Número de páginas16
PublicaciónCurrent Topics in Medicinal Chemistry
Volumen20
N.º25
DOI
EstadoPublicada - 2020

Huella

Profundice en los temas de investigación de 'Exploring the potential of neuroproteomics in Alzheimer's disease'. En conjunto forman una huella única.

Citar esto